Literature DB >> 7864832

Interaction of non-conjugated olefinic substrate analogues with dopamine beta-monooxygenase: catalysis and mechanism-based inhibition.

S R Sirimanne1, S W May.   

Abstract

The reaction of dopamine beta-monooxygenase (DBM; EC 1.14.17.1) with the prototypical non-conjugated olefinic substrate, 2-(1-cyclohexenyl)ethylamine (CyHEA) [see Sirimanne and May (1988) J. Am. Chem. Soc. 110, 7560-7561], was characterized. CyHEA undergoes facile DBM-catalysed allylic hydroxylation to form (R)-2-amino-1-(1-cyclohexenyl)ethanol (CyHEA-OH) without detectable epoxidation or allylic hydroxylation to form (R)-2-amino-1-(1-cyclohexenyl)ethanol (CyHEA-OH) without detectable epoxidation or allylic rearrangement, and with stereochemistry consistent with that of DBM-catalysed benzylic hydroxylation and sulphoxidation. The kcat. of 90 s-1 for CyHEA oxygenation is about 75% of the kcat. for tyramine, the substrate commonly used in assays of DBM activity. DBM-catalysed oxygenation of CyHEA also results in mechanism-based inactivation of DBM, with the inactivation reaction yielding kinact. = 0.3 min-1 at pH 5.0 and 37 degrees C, and a partition ratio of 16,000. Although both CyHEA turnover and inactivation exhibit normal kinetics, CyHEA processing also results in gradual depletion of copper from DBM; however, mechanism-based irreversible DBM inactivation occurs independent of this copper depletion when sufficient copper is present in the assay solution. A likely mechanism for turnover-dependent DBM inactivation by CyHEA involves initial abstraction of an allylic hydrogen to form a resonance-stabilized allylic radical, which can then either partition to product or undergo attack by an active-site residue. Acyclic, non-conjugated olefinic analogues exhibit diminished substrate activity toward DBM. Thus, kcat. for oxygenation of cis-2-hexenylamine, which also produces only allylic alcohol product, is only 14% of that for CyHEA. Similarly, kinact./KI for turnover-dependent inactivation by the acyclic olefin 2-aminomethyl-1-pentene is more than an order of magnitude smaller than that for benzylic olefins. Our results establish that DBM catalyses allylic oxygenation of a number of non-conjugated olefinic substrate analogues with neither epoxidation nor allylic rearrangement occurring. The absence of epoxide products from non-conjugated olefinic substrates implies an inability of the activated copper-oxygen species of DBM to effect radical cation formation from a non-conjugated olefinic moiety. The striking contrast between DBM and cytochrome P-450, which carries out both epoxidation and allylic oxidation with non-conjugated olefinic substrates, is probably a reflection of the differences in redox potential of the activated oxygen species operative for these two enzymes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864832      PMCID: PMC1136484          DOI: 10.1042/bj3060077

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  The enzymatic conversion of 3,4-dihydroxyphenylethylamine to norepinephrine.

Authors:  E Y LEVIN; B LEVENBERG; S KAUFMAN
Journal:  J Biol Chem       Date:  1960-07       Impact factor: 5.157

2.  Studies of enzyme-mediated reactions. Part VII. Stereospecific syntheses of tritium-labelled (2R)- and (2S)-dopamines: stereochemical course of hydroxylation of dopamine by dopamine beta-hydroxylase (E.C. 1.14.17.1).

Authors:  A R Battersby; P W Sheldrake; J Staunton; D C Williams
Journal:  J Chem Soc Perkin 1       Date:  1976

3.  Demonstration of the ascorbate dependence of membrane-bound dopamine beta-monooxygenase in adrenal chromaffin granule ghosts.

Authors:  H H Herman; K Wimalasena; L C Fowler; C A Beard; S W May
Journal:  J Biol Chem       Date:  1988-01-15       Impact factor: 5.157

4.  Dopamine beta-hydroxylase. Demonstration of enzymatic ketonization of the product enantiomer S-octopamine.

Authors:  S W May; R S Phillips; P W Mueller; H H Herman
Journal:  J Biol Chem       Date:  1981-03-10       Impact factor: 5.157

5.  Ascorbate depletion as a consequence of product recycling during dopamine beta-monooxygenase catalyzed selenoxidation.

Authors:  S W May; H H Herman; S F Roberts; M C Ciccarello
Journal:  Biochemistry       Date:  1987-03-24       Impact factor: 3.162

6.  Inhibitors of dopamine beta-hydroxylase. 3. Some 1-(pyridylmethyl)imidazole-2-thiones.

Authors:  S T Ross; L I Kruse; E H Ohlstein; R W Erickson; M Ezekiel; K E Flaim; J L Sawyer; B A Berkowitz
Journal:  J Med Chem       Date:  1987-08       Impact factor: 7.446

7.  Alternate substrates of dopamine beta-hydroxylase. I. Kinetic investigations of benzyl cyanides as substrates and inhibitors.

Authors:  G Colombo; B Rajashekhar; D P Giedroc; J J Villafranca
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

8.  Mechanism-based inactivation of dopamine beta-monooxygenase by beta-chlorophenethylamine.

Authors:  J B Mangold; J P Klinman
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

9.  Dopamine-B-hydroxylase: suicide inhibition by the novel olefinic substrate, 1-phenyl-1-aminomethylethene.

Authors:  S W May; P W Mueller; S R Padgette; H H Herman; R S Phillips
Journal:  Biochem Biophys Res Commun       Date:  1983-01-14       Impact factor: 3.575

10.  Mechanism-based inactivation of dopamine beta-hydroxylase by p-cresol and related alkylphenols.

Authors:  P J Goodhart; W E DeWolf; L I Kruse
Journal:  Biochemistry       Date:  1987-05-05       Impact factor: 3.162

View more
  1 in total

1.  Inactivation of peptidylglycine α-hydroxylating monooxygenase by cinnamic acid analogs.

Authors:  Neil R McIntyre; Edward W Lowe; Matthew R Battistini; James W Leahy; David J Merkler
Journal:  J Enzyme Inhib Med Chem       Date:  2015-05-29       Impact factor: 5.051

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.